A common polymorphism (rs2373115) in the GRB-associated binding protein 2 (GAB2) gene has been recently associated with the risk of developing Alzheimer's disease (AD) in 644 apolipoprotein E (ApoE) epsilon4 carriers. In order to assess the involvement of the GAB2 polymorphism in the risk of developing AD, we analyzed the genotype and allele distributions of the GAB2 rs2373115 polymorphism in 579 Italian subjects. Our results support a possible implication of GAB2 genetic variant in AD. However, the observed association was confined to ApoE epsilon4 non-carriers, thus suggesting a possible role of GAB2 as an independent risk factor for AD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3233/JAD-2009-1005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
LncRNA NEAT1 Promotes Vascular Endothelial Cell Dysfunction via miR-218-5p/GAB2 and Serves as a Diagnostic Biomarker for Deep Vein Thrombosis.
Clin Appl Thromb Hemost
June 2023
Department of Clinical Laboratory, Affiliated Hospital of PanZhiHua University, Panzhihua, China.
Objective: Deep vein thrombosis (DVT) is a common peripheral disease. This study aimed to elucidate the diagnostic biomarker of lncRNA nuclear-enriched abundant transcript 1 (NEAT1) in the DVT, and explore possible mechanisms in Human umbilical vein endothelial cells (HUVECs).
Methods: 101 patients with lower extremity DVT and 82 healthy controls were enrolled.
Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes.
Genome Med
June 2022
Department of Dermatology, University of California San Francisco, San Francisco, CA, USA.
Article Synopsis
- Acral and mucosal melanomas are aggressive forms of melanoma with unique genomic characteristics, showing fewer mutations but more structural alterations compared to cutaneous melanomas.
- The study analyzed sequencing data from 240 melanoma samples to identify significant mutations and copy number variations, highlighting potential tumor suppressor and oncogene roles of specific genes like PTPRJ, FER, and SKP2.
- Findings included distinct mutation patterns for acral and mucosal subtypes, revealing unique amplifications and mutations that could aid in understanding their biology and potential treatment avenues.
A novel GAB2::BRAF fusion in cutaneous non-Langerhans-cell histiocytosis with systemic involvement.
J Cutan Pathol
August 2022
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
Several mutations and gene fusions involved in the mitogen-activated protein kinase (MAPK) pathway have been reported in histiocytic neoplasms including Langerhans cell histiocytosis and non-Langerhans-cell histiocytosis (NLCH). We identified a GAB2::BRAF fusion in a cutaneous lesion from a 22-year-old woman who presented with central diabetes insipidus and red/brown papules on her face, oral mucosa, axilla, and groin. Skin biopsy showed a CD68+, S100-, and CD1a- histiocytic proliferation consistent with NLCH, best clinically classified as xanthoma disseminatum.
View Article and Find Full Text PDFDetermination of tipping point in course of PM organic extracts-induced malignant transformation by dynamic network biomarkers.
J Hazard Mater
March 2022
Department of Toxicology, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou 510080, China. Electronic address:
Article Synopsis
- Dynamic network biomarkers (DNBs) help identify crucial molecules linked to the onset of PM-induced lung cancers by analyzing gene expression over 16 weeks.
- A composition index (CI) highlighted a significant group of genes at the 10-week mark, indicating a tipping point for malignancy.
- Manipulating these core DNB genes demonstrated strong effects on cancerous traits and cell growth, revealing their roles in advancing lung cancer and suggesting new mechanisms for PM-induced transformations.
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo.
Leukemia
April 2022
Institute of Molecular Medicine and Cell Research, ZBMZ, Faculty of Medicine, University of Freiburg, 79104, Freiburg, Germany.
Internal tandem duplications (ITD) of the FMS-like tyrosine kinase 3 (FLT3) predict poor prognosis in acute myeloid leukemia (AML) and often co-exist with inactivating DNMT3A mutations. In vitro studies implicated Grb2-associated binder 2 (GAB2) as FLT3-ITD effector. Utilizing a Flt3-ITD knock-in, Dnmt3a haploinsufficient mouse model, we demonstrate that Gab2 is essential for the development of Flt3-ITD driven AML in vivo, as Gab2 deficient mice displayed prolonged survival, presented with attenuated liver and spleen pathology and reduced blast counts.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!